INTECH BIOPHARM CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.3 TWD | -0.18% |
|
+1.11% | -8.70% |
| Sales 2022 | 23.65M 726K 60.56M | Sales 2023 | 25.85M 794K 66.2M | Capitalization | 4.11B 126M 10.52B |
|---|---|---|---|---|---|
| Net income 2022 | -328M -10.07M -840M | Net income 2023 | -338M -10.38M -866M | EV / Sales 2022 | 208 x |
| Net Debt 2022 | 1.03B 31.76M 2.65B | Net Debt 2023 | 837M 25.72M 2.14B | EV / Sales 2023 | 191 x |
| P/E ratio 2022 |
-11.8
x | P/E ratio 2023 |
-10.6
x | Employees | 82 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 50.7% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.18% | ||
| 1 week | +1.11% | ||
| Current month | -1.62% | ||
| 1 month | -2.33% | ||
| 3 months | -4.55% | ||
| 6 months | +5.61% | ||
| Current year | -8.70% |
1 week
26.60
28.00
1 month
25.8029.20
Current year
25.8031.40
1 year
24.0037.60
3 years
18.0046.75
5 years
11.4546.75
10 years
11.45126.00
| Managers | Title | Age | Since |
|---|---|---|---|
Wei Hsiu Wu
CEO | Chief Executive Officer | - | 01/11/01 |
Chien Yao Yang
DFI | Director of Finance/CFO | - | 23/13/23 |
Chih Hui Lin
CHM | Chairman | - | 28/10/28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chih Hui Lin
CHM | Chairman | - | 28/10/28 |
Te Chien Chou
BRD | Director/Board Member | 66 | 02/14/02 |
Wei Hsiu Wu
CEO | Chief Executive Officer | - | 01/11/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 27.3 | -0.18% | 62,102 |
| 25/24/25 | 27.35 | +1.48% | 144,099 |
| 24/24/24 | 26.95 | +0.94% | 95,323 |
| 23/24/23 | 26.7 | -1.11% | 111,437 |
| 22/24/22 | 27 | 0.00% | 165,659 |
End-of-day quote Taipei Exchange, April 26, 2024
More quotes
INTECH BIOPHARM LTD. is a Taiwan-based company principally engaged in the research, development, manufacture and sales of inhalants and related products. The Company's main products include respiratory drugs, the Duasma hexafluoroacetone (HFA) metered-dose inhalers (MDIs) and the Synvent HFA MDIs. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
09/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -8.70% | 115M | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B | |
| +3.90% | 1.65B |
- Stock Market
- Equities
- 6461 Stock
